Wire Stories
552The Warehouse Robot Market in Japan to 2028: Data for Robot Types, Applications, and End-user Industries – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Warehouse Robot Market in Japan to 2028” report has been added to ResearchAndMarkets.com’s offering. The report offers the most up-to-date...
- 559
Indian Diagnostic Specialty Antibodies Market to 2027: Demand and Supply Conditions, Key Trends and Future Prospects – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Diagnostic Specialty Antibodies Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027” report has been added to...
- 563
Mevion Selected to Equip Proton Therapy Center at Tongji Hospital in China
LITTLETON, Mass.–(BUSINESS WIRE)–Mevion Medical Systems today announced it has been selected by Tongji Hospital of Tongji Medical College, Huazhong University of Science...
- 566
Indian Luxury Perfume Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Luxury Perfume Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s...
- 557
India Affordable Housing Market to 2027 – Featuring TATA Housing Development, Migsun and WorldHaus Construction Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Affordable Housing Market, By Providers (Government, Private Builders, Public-Private Partnership), By Income Category (EWS, LIG, MIG), By Size of...
- 783
PyeongChang Peace Forum 2022 To Be Held Under Slogan of ‘Peace, Here and Now!’
Held as a hybrid event combining an offline venue and online channels over three days from Feb. 22 Will share and spread...
- 641
Prestige BioPharma’s Herceptin Biosimilar, Tuznue®, Receives EU-GMP Certification
SINGAPORE–(BUSINESS WIRE)–Prestige BioPharma Limited (950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, announced that the manufacturing facility for...
- 529
ENHERTU® Significantly Improved Both Progression-Free and Overall Survival in DESTINY-Breast04 Trial in Patients with HER2 Low Metastatic Breast Cancer
First HER2 low metastatic breast cancer phase 3 results for Daiichi Sankyo and AstraZeneca’s ENHERTU offer potential to redefine how the disease...
- 557
Ecoppia Signs a First Ever Hybrid Project of 400MW With Market Leader Azure Power, Featuring Multiple Robotic Solutions on One Site
Ecoppia’s versatile portfolio answers the growing needs of large IPP’s such as Azure Power, providing a holistic solution for even the most...
- 590
Nipa Cloud Selects Juniper Networks to Help Accelerate Digital Transformation Across Thailand’s Enterprises
The latest network infrastructure upgrades will further enable Thailand’s push into the digital economy, in line with government ‘Thailand 4.0’ policy and...
